Updated ESMO Clinical Practice Guideline on #Venousthromboembolism in cancer pts. Primary thromboprophylaxis may be considered in HR ambulatory pts using validated risk models. Anticoagulant #VTE tx effective but may be associated w/ increased bleeding. ow.ly/Hhsf50MmmHM

Just out our experience on cancer-related thromboembolism 🇮🇹🇩🇪 A fifteen-year history of team-working, commitment and stubbornness.Tricky at first, rewarding after all 💪@FlorianLordick Michele Arcopinto @ Lorenzo Gervaso, MD PhD FRANCESCA SPADA Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Monica Milano

News outlet on Medscape 📰 They say about ONKOTEV 📢 New Cancer-Related VTE Risk Prediction Model Validated medscape.com/viewarticle/98… via Medscape

Just released our last experience about microsatellite assessment on endoscopic biopsies of LA EGJ and gastric cancer!! 🔬a great example of multidisciplinary work! IEO Chiara A. Cella urlsand.esvalabs.com/?u=https%3A%2F…

Leaving for San Diego 🇺🇸 ✈️ #ASH65 #CancerResearch #thrombosis #IEO

Thank you ASH for this opportunity! Something has been sown, but there’s still much work to do to see the results. Let’s getting on! Lorenzo Gervaso, MD PhD IEO Fondazione IEO-MONZINO ASH

If interested in the role of the microbiome i gastric cancer take a look ti our review just published in ESMO Gastrointestinal Oncology 📢 Chiara A. Cella Lorenzo Gervaso, MD PhD Lizzy Smyth @FlorianLordick Carmine Valenza IEO 👇 sciencedirect.com/science/articl…

Exited to share our last contribution on Journal for ImmunoTherapy of Cancer about neoadj immunotherapy in GI cancers! 🔹We discussed current evidence and how to incorporate it into practice. Thanks to all colleagues and friends!! 👏🏻Chiara A. Cella Davide Ciardiello FRANCESCA SPADA Lavinia Benini

30000 euros were raised with 'La Ricerca è nell’aria': the bicycle drive to support research in gastroesophageal cancers 🌸🚴🏻‍♀️🎗️Fondazione IEO-MONZINO IEO FiabCremasco Crema on line

Asco 2024: chi sono i 7 ricercatori italiani premiati con i Merit Award - la Repubblica ⭐️ Super Matteo Repetto & Antonio Marra ⭐️ repubblica.it/salute/dossier…

🔥PLENARY Session #ASCO24🔥 Perioperative chemotherapy (FLOT) to neoadjuvant chemoradiation (CROSS) in patients with adenocarcinoma of the esophagus 🔎 ESOPEC phase III trial, 438 patients 👉R0 180 vs 171 👉pCR 17 vs 10% 👉mOS 66 vs 37 mo 👉3yr OS: 57.4 vs 50.7% 🧐FLOT improves

Don’t forget to cast your vote 🇮🇹G Curigliano MD PhD ESMO - Eur. Oncology

❓ How to treat CUPs with GI profile • Favorable: FOLFOX/FOLFIRI • Unfavorable: no difference between platinum based-regimens. 📣 Happy to share our contribution on unfavorable GI-like CUPs Thanks to all the co-authors! esmoopen.com/article/S2059-…

Thanks guys for supporting each other! Grateful 😊 oncodaily.com/blog/124617 Dario Trapani Lorenzo Gervaso, MD PhD IEO

With his huge effort Lorenzo Guidi provided new insights about CUPs with GI profile. Let’s give a look to our new paper. oncodaily.com/insight/123693